Bunge Defies Market Downturn with 0.81% Rally as $300M Trading Volume Ranks 420th, Shares Up 57% in 12 Months

Market Snapshot

On March 10, 2026, Bunge (BG) closed with a 0.81% gain, outperforming the broader market amid a 0.50% decline in the S&P 500 and a 0.57% drop in the Energy sector. The stock traded a volume of $300 million, ranking 420th in market activity for the day. Despite the broader downturn, BG’s performance highlighted its resilience within the Consumer Defensive sector, with shares trading 1.2% above its 20-day simple moving average (SMA) and 8.4% above its 50-day SMA. Over the past year, BG shares have surged 57.04%, nearing their 52-week highs, reflecting sustained investor confidence.

Key Drivers

Shareholder Returns and Capital Allocation

Bunge announced a $3 billion share repurchase program, committing to return at least 50% of its discretionary cash flow to shareholders through dividends and buybacks. This move underscores the company’s confidence in its long-term cash generation and aligns with its updated capital allocation strategy. The repurchase plan, authorized by the board, allows for flexibility in timing and execution, including adherence to Rule 10b5-1 trading protocols to ensure transparency. Analysts view this as a signal of management’s belief in the stock’s undervaluation and a strategic tool to enhance shareholder value.

Mid-Cycle EPS Guidance and Strategic Growth

The company raised its mid-cycle earnings per share (EPS) baseline to $13, with a target of $15 by 2030, reflecting optimism about its integrated agribusiness platform. This update follows the successful integration of Viterra and a pipeline of projects aimed at optimizing operations and expanding market reach. CEO Greg Heckman emphasized the role of global scale and infrastructure in driving efficiency, particularly in connecting farmers with consumers. While Q4 2025 earnings exceeded expectations, the company tempered annual guidance to $7.50–$8 per share for 2026, citing softer near-term demand. The revised target balances short-term challenges with long-term growth prospects.

Analyst Optimism and Market Positioning

Analysts remain bullish on Bunge, with a consensus Buy rating and an average price target of $119.77. Recent upgrades from JPMorgan, Barclays, and UBS—raising targets to $130, $135, and $145, respectively—reflect confidence in the company’s strategic initiatives and financial discipline. The stock’s technical indicators show mixed signals: a neutral RSI of 55.18 suggests neither overbought nor oversold conditions, while the MACD’s bearish crossover below its signal line indicates caution. However, BG’s proximity to key resistance levels ($125) and its strong 12-month performance position it as a potential outperformer in a challenging market.

Macroeconomic and Sectoral Context

Bunge’s outperformance contrasts with broader market weakness, particularly in energy and industrials. The company’s focus on essential commodities—food, feed, and fuel—provides stability amid economic volatility. Its exposure to ETFs further amplifies sensitivity to fund flows, though current inflows remain modest. With its 2026 earnings report scheduled for May 6 and a P/E ratio of 24.1x, the stock is priced at a discount to its long-term growth potential. Management’s emphasis on sustainability, digital innovation, and supply chain efficiency positions Bunge to navigate macroeconomic headwinds while capitalizing on structural trends in global agriculture.